Immunic | VTL - Ebit

Aktienkurs
1.28
Täglich Wechseln
-0.04 -3.03%
Monatlich
25.49%
Jährlich
3.23%
Q1 Prognose
1.28




Ebit Veränderung Datum
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD 56.04M 63.94M 2025-12
CSL USD 2.64B 116M 2025-12
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Grifols EUR 320.55M 91.01M 2025-12
Immunic USD -22.81M 756K 2024-06
Insmed USD -249.71M 11.64M 2025-12
Omeros USD -48.15M 7.25M 2023-09
OraSure Technologies USD -13.59M 2.13M 2025-12
Quidel USD -37.3M 82.5M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Xoma USD -10.08M 4.4M 2024-06